We are live on ! Find out more
ARAV

Aravive, Inc. Common Stock

Delisted

ARAV was delisted on the 26th of January, 2024.

50 hedge funds and large institutions have $17M invested in Aravive, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 16 increasing their positions, 21 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more call options, than puts

Call options by funds: $116K | Put options by funds: $90K

18% less funds holding

Funds holding: 6150 (-11)

24% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 21

40% less capital invested

Capital invested by funds: $28.3M → $17M (-$11.3M)

73% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 15

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
50
Holders Change
-11
Holders Change %
-18.03%
% of All Funds
1.14%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
4
Increased
16
Reduced
21
Closed
15
Calls
$116K
Puts
$90K
Net Calls
+$26K
Net Calls Change
-$116K
Name Holding Trade Value Shares
Change
Change in
Stake
NLVP
1
New Leaf Venture Partners
New York
$3.47M +$406K +38,567 +10%
BBA
2
Baker Bros. Advisors
New York
$3.4M
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.64M +$11.1K +1,057 +0.5%
BlackRock
4
BlackRock
New York
$1.56M -$32.1K -3,051 -2%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$984K +$126K +11,944 +11%
AC
6
Ascend Capital
California
$783K -$34K -3,225 -3%
Millennium Management
7
Millennium Management
New York
$639K -$621K -58,922 -44%
Renaissance Technologies
8
Renaissance Technologies
New York
$615K +$257K +24,436 +50%
NTC
9
NF Trinity Capital
Hong Kong
$343K
Morgan Stanley
10
Morgan Stanley
New York
$300K -$34K -3,227 -8%
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
$295K +$60K +5,693 +19%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$276K -$2K -190 -0.6%
Goldman Sachs
13
Goldman Sachs
New York
$274K -$232K -22,052 -40%
JP Morgan Chase
14
JP Morgan Chase
New York
$254K +$12.9K +1,222 +4%
Jacobs Levy Equity Management
15
Jacobs Levy Equity Management
New Jersey
$240K +$301K +28,578 New
GCP
16
GSA Capital Partners
United Kingdom
$236K -$204K -19,339 -41%
SIM
17
Spark Investment Management
New York
$213K -$41.8K -3,971 -13%
Two Sigma Advisers
18
Two Sigma Advisers
New York
$206K -$22.7K -2,150 -8%
Two Sigma Investments
19
Two Sigma Investments
New York
$144K -$210K -19,927 -54%
BCM
20
Bridgeway Capital Management
Texas
$119K
California Public Employees Retirement System
21
California Public Employees Retirement System
California
$118K +$38.6K +3,659 +35%
Acadian Asset Management
22
Acadian Asset Management
Massachusetts
$117K
Northern Trust
23
Northern Trust
Illinois
$86K -$9.45K -897 -8%
AIM
24
Alambic Investment Management
California
$76K -$17K -1,616 -15%
BCM
25
BlueCrest Capital Management
Jersey
$59K +$21K +1,990 +40%

ARAV Hedge Fund Activity: Q3 2018 in Review

50 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Aravive, Inc. Common Stock (ARAV) for Q3 2018, worth a combined $17M — down 40% from $28.3M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of ARAV and 4 opened new positions — a net loss of 11 holders — while 21 trimmed existing stakes and 16 added.

The largest buyer was New Leaf Venture Partners, adding an estimated $406K. The largest seller was Nexthera Capital, exiting entirely with an estimated $1.01M sold.

  • 50 institutional investors held Aravive, Inc. Common Stock (ARAV) as of Q3 2018, down from 61 in Q2 2018.
  • Funds reported $17M of Aravive, Inc. Common Stock stock for Q3 2018, down 40% quarter-over-quarter.
  • 4 funds opened new Aravive, Inc. Common Stock positions in Q3 2018 and 15 closed out, a net change of -11 holders.
  • The largest Aravive, Inc. Common Stock buyer in Q3 2018 was New Leaf Venture Partners, an estimated $406K added.
  • The largest Aravive, Inc. Common Stock seller in Q3 2018 was Nexthera Capital, an estimated $1.01M sold.

Based on aggregated 13F filings for Q3 2018.